Barinthus Biotherapeutics Plc. - ADR Live Stock Price Today, Share Analysis and Chart

Name: Barinthus Biotherapeutics Plc. - ADR: Is Infosys Ltd. worth buying?
Item: Barinthus Biotherapeutics Plc. - ADR
Rating: 1.83033325
Author: Trendlyne DVM scores

about

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment...

1.17 0.05 (4.46%)

59.93% Fall from 52W High

28,072

XNAS Volume

XNAS 02 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

26.8 / 100

Technically Neutral

46.4 / 100

1Yr Price target upside is 285%

2 analysts

Barinthus Biotherapeutics ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Barinthus Biotherapeutics Plc. - ADR Live Stock Price Today, Share Analysis and Chart

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment...

59.93% Fall from 52W High

SWOT Analysis

Barinthus Biotherapeutics ... Live Price Chart